2021 annual financial data
Axsome Therapeutics 2021 Operating margin
Direct answer
Operating margin was -1,413.95%.
Operating income was -124,706,930 USD and net income was -134,943,391 USD.
Operating cash flow was -108,226,000 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,819,786 USD
- Operating income
- -124,706,930 USD
- Net income
- -134,943,391 USD
- Operating cash flow
- -108,226,000 USD